(Q37845833)

24 August 2017

1 reference

title

High-dose chemotherapy and stem cell rescue for high-risk Ewing's family of tumors (English)

1 reference

24 August 2017

1 reference

Joseph Rosenthal

1

1 reference

24 August 2017

Anna B Pawlowska

series ordinal

2

1 reference

24 August 2017

publication date

1 February 2011

1 reference

Expert Review of Anticancer Therapy

24 August 2017

published in

1 reference

24 August 2017

volume

11

1 reference

24 August 2017

issue

2

1 reference

24 August 2017

page(s)

251-262

1 reference

Cancer incidence, survival, and mortality for children younger than age 15 years

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.215

Ewing and osteogenic sarcoma: evidence for multidisciplinary management

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.215

Ploidy and karyotype complexity are powerful prognostic indicators in the Ewing's sarcoma family of tumors: a study by the United Kingdom Cancer Cytogenetics and the Children's Cancer and Leukaemia Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.215

Survival after recurrence of Ewing's sarcoma family of tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.215

Overexpression of p53 protein in primary Ewing's sarcoma of bone: relationship to tumour stage, response and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.215

High-dose chemoradiotherapy (HDC) in the Ewing family of tumors (EFT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.215

Ewing's sarcoma of the bone: ESMO clinical recommendations for diagnosis, treatment and follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.215

Primary disseminated multifocal Ewing sarcoma: results of the Euro-EWING 99 trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.215

Multidisciplinary treatment of primary Ewing's sarcoma of bone. A 6-year experience of a European Cooperative Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.215

Outcome after relapse in an unselected cohort of children and adolescents with Ewing sarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.215

Prognostic factors for patients with Ewing sarcoma (EWS) at first recurrence following multi-modality therapy: A report from the Children's Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.215

Primary metastatic (stage IV) Ewing tumor: survival analysis of 171 patients from the EICESS studies. European Intergroup Cooperative Ewing Sarcoma Studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.215

Total body MRI-governed involved compartment irradiation combined with high-dose chemotherapy and stem cell rescue improves long-term survival in Ewing tumor patients with multiple primary bone metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.215

Outcome in 43 children presenting with metastatic Ewing sarcoma: the St. Jude Children's Research Hospital experience, 1962 to 1992.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.215

Prognostic significance of tumor volume in localized Ewing's sarcoma of bone in children and adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.215

High-dose melphalan with autologous marrow for treatment of advanced neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.215

Phase II study of high-dose thiotepa and hematopoietic stem cell transplantation in children with solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.215

Fractionated high-dose cyclophosphamide for advanced pediatric solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.215

Improvement over time in outcome for children with acute lymphoblastic leukemia in second remission given hematopoietic stem cell transplantation from unrelated donors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.215

Impact of high-dose busulfan plus melphalan as consolidation in metastatic Ewing tumors: a study by the Société Française des Cancers de l'Enfant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.215

Tandem transplant of peripheral blood stem cells for patients with poor-prognosis Hodgkins's disease or non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.215

Tandem autotransplant as first-line consolidative treatment in poor-risk aggressive lymphoma: a pilot study of 36 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.215

High-dose therapy for patients with primary multifocal and early relapsed Ewing's tumors: results of two consecutive regimens assessing the role of total-body irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.215

High-dose therapy with hematopoietic stem cell rescue in patients with poor prognosis Ewing family tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.215

Gene-marking to trace origin of relapse after autologous bone-marrow transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.215

Incidence and prognostic value of tumour cells detected by RT-PCR in peripheral blood stem cell collections from patients with Ewing tumour

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.215

Tumor cell contamination in re-infused stem cell autografts: does it have clinical significance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.215

Allogeneic and autologous stem-cell transplantation in advanced Ewing tumors. An update after long-term follow-up from two centers of the European Intergroup study EICESS. Stem-Cell Transplant Programs at Düsseldorf University Medical Center, German

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.215

NK cells recognize and lyse Ewing sarcoma cells through NKG2D and DNAM-1 receptor dependent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.215

High-dose iodine-131-metaiodobenzylguanidine with haploidentical stem cell transplantation and posttransplant immunotherapy in children with relapsed/refractory neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.215

High-dose chemotherapy with autologous stem cell rescue for children with high risk and recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.215

Long-term follow up of high-dose chemotherapy with autologous stem cell rescue in adults with Ewing tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.215

Does consolidation with autologous stem cell transplantation improve the outcome of children with metastatic or relapsed Ewing sarcoma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.215

Tandem high-dose chemotherapy with autologous peripheral hematopoietic progenitor cell rescue as consolidation therapy for patients with high-risk Ewing family tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.215

Pattern of relapse in 290 patients with nonmetastatic Ewing's sarcoma family tumors treated at a single institution with adjuvant and neoadjuvant chemotherapy between 1972 and 1999

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.215

Treatment of High-Risk Neuroblastoma With Triple-Tandem High-Dose Therapy and Stem-Cell Rescue: Results of the Chicago Pilot II Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERA.10.215

21 January 2018

Identifiers

DOI

10.1586/ERA.10.215

1 reference

24 August 2017

1 reference